Key result
Hemoglobin-bound dinitrosyl iron complexes inhibited the oxidation of tryptophan and tyrosine residues and prevented covalent crosslinks and heme degradation caused by peroxynitrite.
Why the study?
The mechanisms by which hemoglobin-bound dinitrosyl iron complexes protect hemoglobin against peroxynitrite-mediated oxidative modification had not been scrutinized.
Hb-DNICs protect hemoglobin from peroxynitrite-mediated oxidative damage, suggesting a potential biochemical mechanism for protection against myocardial ischemia.
Preclinical findings only; leaves open DNIC utility against oxidative stress pending in vivo validation.
NO, but are also to act as antioxidant and antiradical agents. However, the mechanics of hemoglobin-bound DNICs (Hb-DNICs) protecting Hb against peroxynitrite-caused, mediated oxidative modification have not yet been scrutinized. Through EPR spectroscopy we show that Hb-DNICs are destroyed under the peroxynitrite action in a dose-dependent manner. At the same time, DNICs inhibit the oxidation of tryptophan and tyrosine residues and formation of carbonyl derivatives. They also prevent the formation of covalent crosslinks between Hb subunits and degradation of a heme group. These effects can arise from the oxoferryl heme form being reduced, and they can be connected with the ability of DNICs to directly intercept peroxynitrite and free radicals, which emerge due to its homolysis. These data show that DNICs may ensure protection from myocardial ischemia.
No takes yet. Share an insight, caveat, or question.
Kosmachevskaya et al. (2021) studied Oxidative modification by peroxynitrite. Hemoglobin-bound dinitrosyl iron complexes (Hb-DNICs) was evaluated on Oxidative modification of hemoglobin. Hemoglobin-bound dinitrosyl iron complexes inhibited the oxidation of tryptophan and tyrosine residues and prevented covalent crosslinks and heme degradation caused by peroxynitrite.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: